InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,575.98
(
-1.26%
)
Post# of 253171
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JohnWayne

Send PM Follow Ignore
Followers 6
Posts 271
Boards Moderated 0
Alias Born 12/22/2011

JohnWayne

Re: DewDiligence post# 210043

Thursday, 03/23/2017 12:14:08 AM

Thursday, March 23, 2017 12:14:08 AM

Post# of 253171
Standard dosing cycle for CTLA-4 inhibitor. True not just for MYSTIC, but just about all tremelimumab (and Yervoy) studies.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up